mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.01 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.01 |